(Research Report) “The result of the Study of the Social Economic Burden of Chronic Obstructive Pulmonary Disease (COPD)”
date : 1/16/2014
Chronic Obstructive Pulmonary Disease (COPD) is expected to become the third leading cause of death in the world in 2030 by the estimation of the World Health Organization (WHO). In Japan, the mortality rate is also expected to increase. Worsening of quality of life (QOL) is believed to have an implication on the productivity of the workers with COPD. However, we never really have a good grip of how much producitivity lost with the different degrees of COPD symtoms, nor we have a good understanding of the social economical burden of COPD in Japan. This study aims to clarify 1. The actual lost of productivity in COPD patients, 2. The affects on QOL, and 3. The prevalence of potential COPD patients.
1. QOL decreased by the level of severity.
Severity of COPD is classified as non-COPD, potential COPD, and diagnosed COPD in this study. The QOL scores of the participants showed that the QOL significantly decreased by severity of COPD. The results remained the same after adjusted with the confounding factors for age and sex.
2. The lost of time in COPD patients is significantly more than the healhty people.
The lost of time in COPD patients is 4.1 hr significantly longer than the health participants (15.8 hr vs 19.9 hr). The overtime loss due to COPD was estimated to be about 470,000 yen per person per year. Medical cost provided by the medical insurance is added up to another 60,000 yen per person per year.
3. The medical cost and production lost of COPD patients is at least 2,000 billion yen.
It is shown that the medical cost on COPD patients is 1.584 billion yen, cost of production lost is 496 billion yen, adding up to a total cost of 2.080 billion yen lost. It is believed that the total cost of lost is much more larger after incorporating the lost outside the work and the productivity lost of the potential COPD.
《Future Policy Direction》
1. Establishment of a system for early dection and treatment of COPD
Screening by simple spirometer and questionnaire is effective in the early detection of persons with suspected COPD, however it is not regularly used because it is not an essential item in the health examination. Future policy needs to establish a system for early dection and treatment of COPD, so that we can have a more effective health care screening.
2. Train more specialists to enable proper care provision system and treatment
Intervention by health professionals is essential to develop a proper care provision system and the treatment of COPD. However, there are very few respiratory specialists nor certified COPD nurses compared to other fields in Japan. With the increase demands in COPD care, it is essential to train more specialists and nurses in the relevent field.
3. Promotion of collaboration system for the relevant stakeholders
Following the example of diabetes, where the academic and medical association join hands in diabetes management through promoting dialogues and equipping medical doctors for diabetes management, COPD had also made its move in recent years such as the establishment of “Japan COPD management conference”. We expect to build a mechanism that tackles local issues through such collaboration of relevent stakeholders.
4. Promotion of populational awareness
The level of populational awareness of the word COPD is hope to increased from 25% to 80% through the promotion of Healthy Japan 21 (Second). The word of COPD needs to have a wide recognition as it helps to lead to early dection of the disease. Also, it is necessary to have a right perspective on COPD among the health care workers and relevant health sectors.
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)